类风湿关节炎慢病管理专家指导建议

Expert recommendations for the chronic disease management of rheumatic arthritis

类风湿关节炎(RA)是一种全身性、慢性自身免疫病。据估计,我国约有500万RA患者,是RA高疾病负担国家。由于患者人群基数大,病程长,治疗达标率低,致残比例高,给患者、家庭、社会造成了严重影响。为此,海峡两岸医药卫生交流协会风湿免疫病学专业委员会慢病管理学组在广泛征求意见的基础上,结合RA的疾病特点,提出了全面、连续、主动的科学管理模式,制订了本建议,涉及RA不同管理阶段的10个关键问题,形成16条专家建议,旨在改善患者的诊疗状况,优化诊疗资源的分配,减少社会、家庭及患者的医疗负担。

Rheumatoid arthritis(RA)is a chronic,systemic autoimmune disease that poses a major healthcare challenge.In China,approximately 5 million patients are reported to have RA.Notably,Chinese patients with RA often experience a prolonged disease course and increased disease activity,leading to a substantial disease burden.The Chronic Disease Management Group of the Special Committee on Rheumatology and Immunology of Cross-Straits Medicine Exchange Association has advocated for an all-encompassing,continuous,and proactive scientific management approach for RA.This initiative has culminated in the formulation of the“Expert Recommendations for the Chronic Disease Management of Rheumatoid Arthritis”,a comprehensive guideline developed through extensive consultations and consideration of the unique characteristics of RA.We have outlined 16 expert recommendations,addressing 10 key aspects central to RA management.We aim to enhance treatment outcomes for patients,streamline the distribution of medical resources,and reduce treatment-related burden on society,families,and individuals affected by this condition.